Form 4: Arteris Inc. VP and General Counsel, Paul Alpern, Executes Stock Sale Under 10b5-1 Plan

Paul Alpern, VP and General Counsel of Arteris Inc., sold 3,326 shares of common stock at an average price of $12.3484 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Paul Alpern, the VP and General Counsel of Arteris Inc., sold 3,326 shares of the company's common stock on January 6, 2025.
• The sale was executed under a pre-arranged 10b5-1 trading plan adopted on May 8, 2024.
• The shares were sold at a weighted average price of $12.3484 per share.
• The sale was conducted in multiple transactions with prices ranging from $12.18 to $12.60.
• Following the transaction, Alpern directly owns 61,604 shares of Arteris Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned and scheduled transaction to avoid any accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice for corporate insiders to sell shares without raising concerns about insider trading.
• The reported transaction is similar to other insider sales reported by executives at comparable technology companies.
• The price range of $12.18 to $12.60 is within the typical trading range for Arteris Inc. stock.

Stakeholder Impact

• The stock sale by a company executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

insider trading, stock sale, 10b5-1 plan, securities transaction, Arteris Inc., Paul Alpern